Covid-19 and Sarcopenia: A bibliometric analysis


  • Raju Vaishya Indraprastha Apollo Hospitals image/svg+xml
  • Brij Mohan Gupta Formerly with CSIR-NISTADS, New Delhi 110012, India
  • Yogendra Singh Swami Rama Himalayan University image/svg+xml
  • Abhishek Vaish Indraprastha Apollo Hospitals image/svg+xml



Objective. Covid-19 disease affects all organs of the human body, including muscles. However, the association between Covid-19 and Sarcopenia has not been analyzed bibliometrically. In this study, we performed a bibliometric analysis to identify the current hotspots and highlight future trends.

Design/Methodology/Approach. The Scopus database was used as a data source. We analyzed the following indicators: document type, country, collaboration patterns, affiliation, journal name, and citation patterns. MS-Excell and VOSviewer were employed to map and determine essential topics in this field.

Results/Discussion. 846 publications were retrieved from Scopus. They have received 15651 citations, averaging 18.5 citations per paper (CPP). 29.43% of publications received extramural funding from international agencies and together registered a CPP of 40.66. The USA published the most significant number of publications (n=162). However, the highest CPP and Relative Citation Index (RCI) was registered by China (186.0 and 10.05). “Medicine” contributed the largest global output share (82.98%). The Sapienza Università di Roma, Italy (n=20) was the most productive institution. Whereas, Deutsches Zentrum für Herz-Kreislauf-Forschung e. V. Germany registered the highest CPP and RCI. F. Landi was the most impactful author. The International Journal of Environmental Research and Public Health (n=38) and Nutrients (n=28) were the most productive journals. The most prevalent topics of research, as reflected in keywords by frequency of their appearance, were “Covid-19” (n=810), “Sarcopenia” (n=324), “Skeleton Muscle” (n=309), “Muscle Mass” (n=214), “Grip Strength” (n=199), “Physical Activity” (n=172).

Conclusions. This bibliometric study revealed that papers on ‘Covid-19 and Sarcopenia” received a high number of citations (average of 18.5 CPP) within a short period. Those papers which got external funding received much higher CPP (40.66). Maximum contributory and impactful authors were from High-Income Countries. The highly cited papers were 5.25% of the total publications.


Download data is not yet available.


Aryana, G P S, Daniella, D, Kuswardhani, RAT, Setiati, S. (2022). Acute sarcopenia in elderly with Covid-19: An overlooked problem. Bali Medical Journal, 11(3): 1269–1276. DOI:

Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinková E, Vandewoude M, Zamboni M (2010). European Working Group on Sarcopenia in Older People. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 39(4): 412-23. doi: 10.1093/ageing/afq034. DOI:

Evans WJ. (1995). What is sarcopenia? J Gerontol A Biol Sci Med Sci. 50(Spec): 5–8.

Fan J, Gao Y, Zhao N, Dai R, Zhang H, Feng X, Shi G, Tian J, Chen C, Hambly BD, Bao S. (2020). Bibliometric analysis on Covid-19: A comparison of research between English and Chinese studies. Front Public Health. 8: 477. doi: 10.3389/FPUBH.2020.00477/BIBTEX. DOI:

Gupta BM, Dhawan SM, Ahmed KKM, Mamdapur GM. (2021) Global Research on Covid-19 Disease: A Scientific Assessment of Publications during 2020-21. International Journal of Medicine and Public Health, 11(2):76-84. DOI:

Janssen I, Heymsfield SB, Ross R. (2002). Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc. 50: 889–896. DOI:

Malmstrom TK, and Morley JE. (2013). SARC-F: A simple questionnaire to rapidly diagnose sarcopenia. Journal of the American Medical Directors Association, 14(8): 531-532. DOI:

Piotrowicz K, Gąsowski J, Michel JP, Veronese N. (2021). Post-Covid-19 acute sarcopenia: Physiopathology and management. Aging Clin Exp Res 33, 2887–2898. DOI:

Remelli F, Vitali A, Zurlo A, Volpato S. (2019). Vitamin D deficiency and sarcopenia in older persons. Nutrients, 11(12): 2861. doi: 10.3390/nu11122861 DOI:

Robinson S, Cooper C, Aihie Sayer A. (2012). Nutrition and sarcopenia: A review of the evidence and implications for preventive strategies. J Aging Res, 2012: 510801. doi: 10.1155/2012/510801 DOI:

Rosenberg, I. H. (1997). Sarcopenia: origins and clinical relevance. The Journal of Nutrition, 127(5), 990S-991S. DOI:

Sanyaolu A, Okorie C, Marinkovic A, Patidar R, Younis K, Desai P, Hosein Z, Padda I, Mangat J, Altaf M. (2020). Comorbidity and its impact on patients with Covid-19. SN Compr Clin Med., 2(8): 1069–1076. doi: 10.1007/s42399-020-00363-4 DOI:

Schneider SM, Al-Jaouni R, Filippi J, Wiroth JB, Zeanandin G, Arab K, Hébuterne X. (2008). Sarcopenia is prevalent in patients with Crohn’s disease in clinical remission. Inflamm Bowel Dis., 14: 1562–1568. DOI:

Suzan, V, and Suzan, A.A. (2020). A bibliometric analysis of sarcopenia: Top 100 articles. Eur. Geriatr. Med., 12: 185–191. DOI:

Vaishya R, Gupta BM, Misra A, Mamdapurj GM, Vaish A. (2022). Global research in sarcopenia: High-cited papers, research institutions, funding agencies and collaborations, 1993–2022. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 16(11), 102654. DOI:

Vellas B, Fielding RA, Bens C, Bernabei R, Cawthon PM, Cederholm T, Cruz-Jentoft AJ, Del Signore S, Donahue S, Morley J, Pahor M, Reginster JY, Rodriguez Mañas L, Rolland Y, Roubenoff R, Sinclair A, Cesari M. (2018). Implications of ICD-10 for sarcopenia clinical practice and clinical trials: Report by the international conference on frailty and sarcopenia research task force. The Journal of Frailty & Aging, 7: 2-9. DOI:

von Haehling S, Morley JE, Anker SD. (2010). An overview of sarcopenia: facts and numbers on prevalence and clinical impact. J Cachexia Sarcopenia Muscle, . 1(2): 129–133. Doi: 10.1007/ s13539-010-0014-2 DOI:

Wang Y, Tan S, Yan Q, Gao Y. (2023). Sarcopenia and Covid-19 outcomes. Clin Interv Aging., 18: 359-373. doi: 10.2147/CIA.S398386. DOI:

Wu L, He K, Fang D, Qiu X, Xiao W, Lou S, Yong R. (2022). Trends in nutrition research for sarcopenia: A bibliometric analysis. Nutrients, 14(20): 4262. DOI:

Xia L, Zhao R, Wan Q, Wu Y, Zhou Y, Wang Y, Cui Y, Shen X, Wu X. (2020). Sarcopenia and adverse health‐related outcomes: An umbrella review of meta‐analyses of observational studies. Cancer Med., 9(21): 7964–7978. doi: 10.1002/cam4.3428 DOI:

Xiao Y, Deng Z, Tan H, Jiang T, Chen Z. (2022). Bibliometric analysis of the knowledge base and future trends on sarcopenia from 1999–2021. Int. J. Environ. Res. Public Health, 19: 8866 DOI:

Xu Y, Xu JW, You P, Wang BL, Liu C, Chien CW, Tung TH. (2022). Prevalence of sarcopenia in patients with Covid-19: A systematic review and meta-analysis. Front. Nutr., 9: 925606. doi: 10.3389/fnut.2022.925606 DOI:

Yang, M.; Tan, L.; Li, W. (2020). Landscape of sarcopenia research (1989-2018): A bibliometric analysis. J. Am. Med. Dir. Assoc, 21: 436–437. DOI:

Yang J, Jiang T, Xu G, Liu W. (2023) Bibliometrics analysis and visualization of sarcopenia associated with osteoporosis from 2000 to 2022. Journal of Pain Research, 16: 821-837, DOI: 10.2147/JPR.S403648 DOI:

Yuan D, Jin H, Liu Q, Zhang J, Ma B, Xiao W, Li Y. (2022). Publication trends for sarcopenia in the world: A 20-year bibliometric analysis. Front Med (Lausanne), 9: 802651. doi: 10.3389/fmed.2022.802651 DOI:




How to Cite

Vaishya, R., Gupta , B. M., Singh , Y., & Vaish , A. (2023). Covid-19 and Sarcopenia: A bibliometric analysis. Iberoamerican Journal of Science Measurement and Communication, 3(2).